Company intelligence / Profile preview

Genova Diagnostics

Asheville, North Carolina, United Statesgdx.net ↗

Ownership: Private
Employees: ~350
Development stage: Commercial

Overview

Genova Diagnostics offers a broad portfolio of advanced clinical laboratory tests for the prevention and diagnosis of complex chronic diseases. Their most notable products include the GI Effects Comprehensive Stool Profile for digestive health and the NutrEval test for nutritional assessment. The company uses advanced technologies such as 16S rRNA PCR sequencing and MALDI-TOF to deliver actionable insights to healthcare providers[1][2].

Therapeutic areas: Metabolic DisordersEndocrinologyImmunologyOtherPsychiatryRheumatologyGastroenterologyCardiovascular
Industry: Molecular Diagnostics

Partnerships

Collaborates with leading medical institutions such as Johns Hopkins Universityworks with international distributors in over 50 countries

Beyond the preview

Go deeper on Genova Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genova Diagnostics.

Explore the full profile